英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：

flames    音标拼音: [fl'emz]
n. 火焰

火焰


请选择你想看的字典辞典：
单词字典翻译
flames查看　flames　在百度字典中的解释百度英翻中〔查看〕
flames查看　flames　在Google字典中的解释Google英翻中〔查看〕
flames查看　flames　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Small Cell Lung Cancer Clinical Trials
    The clinical trials on this list are for small cell lung cancer All trials on the list are NCI-supported clinical trials, which are sponsored or otherwise financially supported by NCI NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out Clinical trials look at new ways to
  • Small Cell Lung Cancer Clinical Trials - Mayo Clinic Research
    This randomized pilot clinical trial studies the side effects and best dose of naloxegol and to see how well it works in treating patients with stage IIIB-IV non-small cell lung cancer The four cancer types are: Non-Small Cell Lung Cancer (NSCLC) and melanoma that are progressing on checkpoint inhibitor (CPI, generally refers to anti-PD(L
  • Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer
    A phase 1 dose-exploration trial of tarlatamab in patients with previously treated small-cell lung cancer showed encouraging antitumor activity, with a median duration of response of 12 3 months
  • Treatments in Clinical Trials for Small Cell Lung Cancer - Healthline
    Small cell lung cancer (SCLC) often responds well to initial treatment before later relapsing Researchers are continuing to investigate new treatments, such as targeted therapy and immunotherapy
  • MSK Researchers Present Advances in Lung Cancer Treatment at 2025 ASCO . . .
    MSK thoracic medical oncologist and early drug development specialist Helena Yu, MD, presented promising preliminary findings at ASCO from an international phase 2 clinical trial that studied a new medicine called zipalertinib This drug is a targeted therapy developed to treat non-small cell lung cancer (NSCLC) driven by a gene change called an EGFR exon 20 mutation
  • IMDELLTRA® SIGNIFICANTLY REDUCED RISK OF DEATH BY 40% IN SMALL CELL . . .
    "Small cell lung cancer is an extraordinarily aggressive and difficult-to-treat open-label clinical trial evaluating the efficacy and safety of IMDELLTRA as a treatment for patients living with SCLC who progressed on or after a single line of platinum-based chemotherapy 1 Five hundred and nine patients were randomized to receive either
  • Small cell lung cancer - Cancer Research UK
    Read more about A trial of chemoradiotherapy, pembrolizumab, and olaparib for small cell lung cancer (KEYLYNK-013) A trial of MK-7684A and chemotherapy for small cell lung cancer (KeyVibe-008) This trial is looking at a new drug called MK-7684A with chemotherapy to treat small cell lung cancer
  • Small Cell Lung Cancer (SCLC) | LUNGevity Foundation
    In addition to the approved treatments described above, researchers are testing several new types of treatment in clinical trials for people with small cell lung cancer, including targeted therapy and immunotherapy treatments among others 20 Clinical trials are considered a good option for small cell lung cancer patients, per NCCN guidelines
  • Systemic Therapy for Small Cell Lung Cancer: ASCO Guideline Rapid . . .
    In 2023, ASCO published a guideline on systemic therapy for small cell lung cancer Methods A targeted electronic literature search to identify clinical trials in this patient population was conducted and one phase III randomized control trial and one phase II clinical trial were found The original guideline Expert Panel was reconvened to
  • Targeted treatments for small-cell lung cancer
    A rapid screening process identified a two-drug combination that shrank small-cell lung tumors, which are often fatal within weeks of recurrence In a pilot clinical trial, almost two-thirds of people who received the combination to treat recurrent small-cell lung cancer lived for at least six months





中文字典-英文字典  2005-2009